Explore our top industrial systems and high-precision clinical analyzer lines customized for international laboratories.
Established in 2017, Shenzhen BioX Medical Co., Ltd. is a premier manufacturer specializing in high-throughput molecular diagnostic analysis systems, robust genetic testing solutions, and medical-grade clinical laboratory equipment. Headquartered in Shenzhen, China—the world’s epicenter for biotechnology research, advanced medical device engineering, and automated supply chains—we have systematically expanded our capabilities to supply international clients with elite OEM and ODM services.
Operating a state-of-the-art manufacturing facility spanning more than 9,000 square meters, BioX Medical utilizes an array of ISO 13485:2016-compliant cleanrooms, precision calibration stages, and automated optical validation lines. Our workforce, consisting of over 200 industry experts, is dedicated to the multi-disciplinary research, development, and scalable production of clinical testing tools for hospitals, reference laboratories, government biosecurity units, and diagnostic kit developers worldwide.
Our expansive product portfolio bridges physical, chemical, and biological technologies, including:
Information Gain Insight: The molecular diagnostics industry demands a synthesis of thermal control, optical sensitivity, and mechanical stability. BioX Medical achieves sub-0.1°C temperature uniformity across 96-well blocks by integrating customized thermoelectric coolers (TECs) and advanced PID control algorithms. Our optical blocks leverage high-performance CCD/CMOS chips and custom-engineered bandpass filters to isolate fluorescence without channel-to-channel crosstalk.
Utilizing high-purity superparamagnetic bead extraction engines, our systems achieve recovery yields exceeding 98% with an elution time of under 30 minutes, handling sample volumes from 20 to 1000 microliters.
Our real-time PCR platforms boast up to 6 fluorescent detection channels, allowing simultaneous screening for multiple pathogens in a single patient sample, saving reagents and diagnostic time.
From custom optical assembly and tailored plastic injection cartridge tooling to firmware design and diagnostic software branding, we deliver turnkey molecular systems ready for regulatory registration.
As the molecular diagnostics domain moves from traditional qPCR to absolute quantification, BioX Medical is heavily investing in Digital PCR (dPCR) technology. By separating samples into tens of thousands of microfluidic droplets, our next-generation dPCR systems will deliver precise copies-per-microliter measurements without standard curves, offering unprecedented sensitivity for oncology, liquid biopsy, and rare variant detection.
Simultaneously, we are executing a roadmap to integrate Microfluidic Lab-on-a-Chip structures into our POCT (Point-of-Care Testing) platforms. By combining lysis, extraction, amplification, and detection on a single sealed cartridge, we reduce biological contamination risks to zero, opening up fast-turnaround molecular testing for remote clinics, border checkpoints, and mobile field laboratories.
BioX Medical’s instrument suites are designed to serve distinct, demanding environments:
BioX Medical leverages China’s unparalleled industrial supply chain in Shenzhen to optimize component sourcing, mechanical prototyping, and optical alignment processes. By deploying Factory 4.0 principles—including automated robotic assembly arms, live MES (Manufacturing Execution System) tracking, and IoT-enabled quality assurance chambers—we significantly lower production lead times while ensuring a defect rate of less than 0.1%.
Precision Engineering Synergy: In addition to complex optical bio-analytical instruments, our engineering footprint encompasses heavy-duty structural systems, such as 3D flexible welding tables and specialized steel silos for materials processing. This physical engineering expertise ensures that even the internal framing, thermal sink brackets, and chassis of our medical scanners are built to withstand shipping vibrations and harsh ambient conditions, guaranteeing structural durability over decades of laboratory use.
Our 9,000 sqm production site is segmented into isolated clean assembly lines, optical calibration darkrooms, and environmental aging chambers where every diagnostic system undergoes a continuous 72-hour thermal stress test before shipment. By controlling the entire process from structural metalwork to microelectronics assembly internally, we insulate our international clients from supply chain disruptions, assuring steady product delivery schedules.
Distributing medical devices globally requires meticulous compliance with local jurisdictions. BioX Medical provides all exporters and OEM partners with complete regulatory support dossiers, facilitating registrations with the FDA, CE, and country-specific health ministries. Our quality assurance protocols conform strictly to ISO 13485:2016 and ISO 9001:2015 international guidelines.
To support global distribution networks, we offer:
When sourcing OEM molecular testing platforms from a Chinese factory, global procurement departments must focus on quality verification and longevity. Use this checklist to validate your partner's capacity:
Ensure the manufacturer provides full trace logs for thermal block calibration, sensor drift analysis, and cleanroom particulate monitoring reports.
Review strict non-disclosure and intellectual property agreements covering firmware code base, custom PCB layouts, and plastic injection molds.
Validate the capacity to scale production from 10 units for pilot clinical trials to 500+ monthly units during global disease outbreaks.
Take an inside look at our advanced manufacturing floor, assembly zones, and engineering precision capabilities in Shenzhen.
Expert technical insights regarding our OEM services, diagnostic tool engineering, and supply arrangements.
Select from our specialized nucleic acid purification machines, real-time PCR analyzers, and advanced industrial platforms.
BioX Medical
